Biobanking Market (Product: Equipment, Consumables, and Software & Services; Biospecimen Type: Blood Products, Human Tissues, Cell Lines, Nucleic Acids, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Aug 2022| TMR3237A| Transparency

Report Highlights

Biobanking Market – Scope of Report

TMR’s report on the global biobanking market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global biobanking market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global biobanking market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the biobanking market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global biobanking market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global biobanking market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global biobanking market.

The report delves into the competitive landscape of the global biobanking market. Key players operating in the global biobanking market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global biobanking market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market biobanking.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

Frequently Asked Questions (FAQs)

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global Biobanking Market Size (US$ Mn) Forecast, by Product, 2017–2031
  • Table 2 : Global Biobanking Market Size (US$ Mn) Forecast, by Application, 2017–2031
  • Table 3 : Global Biobanking Market Size (US$ Mn) Forecast, by Biospecimen Type, 2017–2031
  • Table 4 : Global Biobanking Market Size (US$ Mn) Forecast, by Storage Type, 2017–2031
  • Table 5 : Global Biobanking Market Size (US$ Mn) Forecast, by Region, 2017–2031
  • Table 6 : North America Biobanking Market Size (US$ Mn) Forecast, by Country, 2017–2031
  • Table 7 : North America Biobanking Market Size (US$ Mn) Forecast, by Product, 2017–2031
  • Table 8 : North America Biobanking Market Size (US$ Mn) Forecast, by Application, 2017–2031
  • Table 9 : North America Biobanking Market Size (US$ Mn) Forecast, by Biospecimen Type, 2017–2031
  • Table 10 : North America Biobanking Market Size (US$ Mn) Forecast, by Storage Type, 2017–2031
  • Table 11 : Europe Biobanking Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 12 : Europe Biobanking Market Size (US$ Mn) Forecast, by Product, 2017–2031
  • Table 13 : Europe Biobanking Market Size (US$ Mn) Forecast, by Application, 2017–2031
  • Table 14 : Europe Biobanking Market Size (US$ Mn) Forecast, by Biospecimen Type, 2017–2031
  • Table 15 : Europe Biobanking Market Size (US$ Mn) Forecast, by Storage Type, 2017–2031
  • Table 16 : Asia Pacific Biobanking Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 17 : Asia Pacific Biobanking Market Size (US$ Mn) Forecast, by Product, 2017–2031
  • Table 18 : Asia Pacific Biobanking Market Size (US$ Mn) Forecast, by Application, 2017–2031
  • Table 19 : Asia Pacific Biobanking Market Size (US$ Mn) Forecast, by Biospecimen Type, 2017–2031
  • Table 20 : Asia Pacific Biobanking Market Size (US$ Mn) Forecast, by Storage Type, 2017–2031
  • Table 21 : Latin America Biobanking Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 22 : Latin America Biobanking Market Size (US$ Mn) Forecast, by Product, 2017–2031
  • Table 23 : Latin America Biobanking Market Size (US$ Mn) Forecast, by Application, 2017–2031
  • Table 24 : Latin America Biobanking Market Size (US$ Mn) Forecast, by Biospecimen Type, 2017–2031
  • Table 25 : Latin America Biobanking Market Size (US$ Mn) Forecast, by Storage Type, 2017–2031
  • Table 26 : Middle East & Africa Biobanking Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 27 : Middle East & Africa Biobanking Market Size (US$ Mn) Forecast, by Product, 2017–2031
  • Table 28 : Middle East & Africa Biobanking Market Size (US$ Mn) Forecast, by Application, 2017–2031
  • Table 29 : Middle East & Africa Biobanking Market Size (US$ Mn) Forecast, by Biospecimen Type, 2017–2031
  • Table 30 : Middle East & Africa Biobanking Market Size (US$ Mn) Forecast, by Storage Type, 2017–2031
  • Figure 1 : Global Biobanking Market Size (US$ Mn) and Distribution (%), by Region, 2021 and 2031
  • Figure 2 : Global Biobanking Market Revenue (US$ Mn), by Product, 2021
  • Figure 3 : Global Biobanking Market Value Share, by Product, 2021
  • Figure 4 : Global Biobanking Market Value Share, by Application, 2021
  • Figure 5 : Global Biobanking Market Value Share, by Biospecimen Type, 2021
  • Figure 6 : Global Biobanking Market Value Share, by Storage Type, 2021
  • Figure 7 : Global Biobanking Market Value Share, by Region, 2021
  • Figure 8 : Global Biobanking Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 9 : Global Biobanking Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 10 : Global Biobanking Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 11 : Global Biobanking Market Value Share Analysis, by Application, 2017 and 2031
  • Figure 12 : Global Biobanking Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 13 : Global Biobanking Market Value Share Analysis, by Biospecimen Type, 2017 and 2031
  • Figure 14 : Global Biobanking Market Attractiveness Analysis, by Storage type, 2022–2031
  • Figure 15 : Global Biobanking Market Value Share Analysis, by Storage Type, 2017 and 2031
  • Figure 16 : Global Biobanking Market Value Share Analysis, by Region, 2017 and 2031
  • Figure 17 : Global Biobanking Market Attractiveness Analysis, by Region, 2022–2031
  • Figure 18 : North America Biobanking Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
  • Figure 19 : North America Biobanking Market Attractiveness Analysis, by Country, 2017–2031
  • Figure 20 : North America Biobanking Market Value Share Analysis, by Country, 2017 and 2031
  • Figure 21 : North America Biobanking Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 22 : North America Biobanking Market Value Share Analysis, by Application, 2017 and 2031
  • Figure 23 : North America Biobanking Market Value Share Analysis, by Biospecimen Type, 2017 and 2031
  • Figure 24 : North America Biobanking Market Value Share Analysis, by Storage Type, 2017 and 2031
  • Figure 25 : North America Biobanking Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 26 : North America Biobanking Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 27 : North America Biobanking Market Attractiveness Analysis, by Biospecimen Type, 2022–2031
  • Figure 28 : North America Biobanking Market Attractiveness Analysis, by Storage Type, 2022–2031
  • Figure 29 : Europe Biobanking Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
  • Figure 30 : Europe Biobanking Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
  • Figure 31 : Europe Biobanking Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 32 : Europe Biobanking Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 33 : Europe Biobanking Market Value Share Analysis, by Application, 2017 and 2031
  • Figure 34 : Europe Biobanking Market Value Share Analysis, by Biospecimen Type, 2017 and 2031
  • Figure 35 : Europe Biobanking Market Value Share Analysis, by Storage Type, 2022–2031
  • Figure 36 : Europe Biobanking Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 37 : Europe Biobanking Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 38 : Europe Biobanking Market Attractiveness Analysis, by Biospecimen Type, 2022–2031
  • Figure 39 : Europe Biobanking Market Attractiveness Analysis, by Storage Type, 2022–2031
  • Figure 40 : Asia Pacific Biobanking Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
  • Figure 41 : Asia Pacific Biobanking Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
  • Figure 42 : Asia Pacific Biobanking Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 43 : Asia Pacific Biobanking Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 44 : Asia Pacific Biobanking Market Value Share Analysis, by Application, 2017 and 2031
  • Figure 45 : Asia Pacific Biobanking Market Value Share Analysis, by Biospecimen Type, 2017 and 2031
  • Figure 46 : Asia Pacific Biobanking Market Value Share Analysis, by Storage Type, 2022–2031
  • Figure 47 : Asia Pacific Biobanking Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 48 : Asia Pacific Biobanking Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 49 : Asia Pacific Biobanking Market Attractiveness Analysis, by Biospecimen Type, 2022–2031
  • Figure 50 : Asia Pacific Biobanking Market Attractiveness Analysis, by Storage Type, 2022–2031
  • Figure 51 : Latin America Biobanking Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
  • Figure 52 : Latin America Biobanking Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
  • Figure 53 : Latin America Biobanking Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 54 : Latin America Biobanking Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 55 : Latin America Biobanking Market Value Share Analysis, by Application, 2017 and 2031
  • Figure 56 : Latin America Biobanking Market Value Share Analysis, by Biospecimen Type, 2017 and 2031
  • Figure 57 : Latin America Biobanking Market Value Share Analysis, by Storage Type, 2022–2031
  • Figure 58 : Latin America Biobanking Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 59 : Latin America Biobanking Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 60 : Latin America Biobanking Market Attractiveness Analysis, by Biospecimen Type, 2022–2031
  • Figure 61 : Latin America Biobanking Market Attractiveness Analysis, by Storage Type, 2022–2031
  • Figure 62 : Middle East & Africa Biobanking Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
  • Figure 63 : Middle East & Africa Biobanking Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
  • Figure 64 : Middle East & Africa Biobanking Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
  • Figure 65 : Middle East & Africa Biobanking Market Value Share Analysis, by Product, 2017 and 2031
  • Figure 66 : Middle East & Africa Biobanking Market Value Share Analysis, by Application, 2017 and 2031
  • Figure 67 : Middle East & Africa Biobanking Market Value Share Analysis, by Storage Type, 2017 and 2031
  • Figure 68 : Middle East & Africa Biobanking Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 69 : Middle East & Africa Biobanking Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 70 : Middle East & Africa Biobanking Market Attractiveness Analysis, by Biospecimen Type, 2022–2031
  • Figure 71 : Middle East & Africa Biobanking Market Attractiveness Analysis, by Storage Type, 2022–2031

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Transparency
Price: $5795

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS